Prevalence of neuroleptic malignant syndrome.
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000453:epidemiology / Q000209:etiology*
D014150:Antipsychotic Agents; D006220:Haloperidol